Neogen Corporation

NASDAQ:NEOG

Medical - Diagnostics & Research

Healthcare
$11.08 +1.79%

+$0.16 today

Market cap
$2.42B
Beta
1.80
P/E (TTM)
-3.3
EPS (TTM)
-$2.80
52W Low $4.56High $11.43

Volume 1.79M

Average 2.53M

NEOG Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Neogen CorporationNASDAQ: NEOG

Net Margin · Q1 FY2027 · quarter ended Aug 2026

Net margin narrows to -5.3%

Net margin was -5.3% in Q1 FY2027, down 22.7 pp from a year earlier. On a trailing-twelve-month basis it was -6.3%, up 111.3 pp year over year. Over 3 fiscal years it widened by 1.9 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 4 analysts of 7.9% for the fiscal year ending May 2027, up from -0.9% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterAug 2026
-5.3%-0.3 pp QoQ
Last fiscal yearMay 2026
-0.9%+121.2 pp YoY
LTMAug 2026
-6.3%+111.3 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-22.7 pp+13.3 pp+36.0 pp
1 year+121.2 pp+8.8 pp-112.3 pp
3 years+1.9 pp+15.7 pp+13.9 pp
5 years+12.7 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2026
-0.9%
Year-over-year change
+121.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How NEOG compares with its peers on the latest reported figures

  • NEOG's LTM Aug 2026 net margin of -6.3% is the lowest of the 7 companies compared; the peer median is 10.9%.
  • Its year-over-year change of +111.3 pp is the highest of 7, against a peer median of +0.2 pp.
  • Over three fiscal years its change of +1.9 pp compares with a peer median of +2.8 pp.
NEOG Competitors Peer median
Net Margin for NEOG and competitors
Company Period LTM level YoY 3-year change
ZTSZoetis Inc.LTM Jun 202627.5% -0.3 pp+2.1 pp
IDXXIDEXX Laboratories, Inc.LTM Sep 202625.4% +0.7 pp+4.5 pp
BCPCBalchem CorporationLTM Sep 202615.4% +0.7 pp+3.7 pp
PAHCPhibro Animal Health CorporationLTM Mar 20266.3% +3.7 pp-1.5 pp
MRKMerck & Co., Inc.LTM Jun 20264.8% -21.0 pp+3.6 pp
ELANElanco Animal Health IncorporatedLTM Sep 2026-2.9% -3.6 pp-3.2 pp
NEOGNeogen CorporationLTM Aug 2026-6.3% +111.3 pp+1.9 pp
Peer median (excluding NEOG) 10.9%+0.2 pp+2.8 pp

Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Revenue527.16M822.45M924.22M894.66M870.4M
Cost of Revenue284.15M416.49M461.59M473.29M461.9M
Gross Profit243.01M405.96M462.64M421.38M408.5M
Gross Margin46.1%49.4%50.1%47.1%46.9%
Research & Development17.05M26.04M22.48M21.09M18.4M
Selling, General & Admin167.35M342.4M382.76M401.97M411.7M
Operating Expenses184.4M368.44M385.21M411.96M430.1M
Depreciation & Amortization24.13M90.47M121.23M125.67M116.3M
EBITDA84.34M124.39M182.6M(937.75M)164.9M
EBITDA Margin16.0%15.1%19.8%-104.8%18.9%
Operating Income58.62M37.52M77.43M9.42M(21.6M)
Operating Margin11.1%4.6%8.4%1.1%-2.5%
Interest Income1.34M3.17M6.36M3.11M0
Interest Expense72K55.96M73.39M71.62M57.6M
Other Income / Expenses1.59M(59.56M)(91.73M)(1.14B)12.6M
Income Before Tax60.21M(22.04M)(14.31M)(1.13B)(9M)
Pre-Tax Margin11.4%-2.7%-1.5%-126.7%-1.0%
Income Tax Expense11.9M828K(4.88M)(41.07M)(1.1M)
Net Income48.31M(22.87M)(9.42M)(1.09B)(7.9M)
Net Margin9.2%-2.8%-1.0%-122.1%-0.9%
EPS (Basic)0.45(0.12)(0.04)(5.03)(0.04)
EPS (Diluted)0.45(0.12)(0.04)(5.03)(0.04)
Weighted Avg Shares107.68M188.88M216.48M216.89M217.5M
Weighted Avg Shares (Diluted)108.02M188.88M216.48M216.89M217.5M

Neogen Corporation

NASDAQ:NEOG

Intrinsic Alpha fair value

Locked

Current Price

$11.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.